MCP
PACB icon

Mirador Capital Partners’s Pacific Biosciences PACB Stock Holding History

Mirador Capital Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$810K Sell
341,725
-757
-0.2% -$1.07K 0.09% 123
2026
Q2 		$575K Sell
342,482
-262,402
-43% -$382K 0.07% 145
2026
Q1 		$798K Buy
604,884
+13,879
+2% +$24.8K 0.11% 109
2025
Q4 		$1.11M Buy
591,005
+9,612
+2% +$18.5K 0.15% 95
2025
Q3 		$744K Buy
581,393
+17,723
+3% +$24K 0.11% 122
2025
Q2 		$699K Buy
563,670
+47,936
+9% +$55.4K 0.11% 116
2025
Q1 		$609K Buy
515,734
+289,148
+128% +$444K 0.11% 119
2024
Q4 		$415K Buy
226,586
+3,374
+2% +$6.59K 0.08% 140
2024
Q3 		$379K Buy
223,212
+161,818
+264% +$266K 0.07% 148
2024
Q2 		$84.1K Sell
61,394
-256,979
-81% -$519K 0.02% 185
2024
Q1 		$1.19M Buy
318,373
+265,835
+506% +$1.56M 0.23% 72
2023
Q4 		$515K Buy
52,538
+26,951
+105% +$220K 0.11% 114
2023
Q3 		$214K Buy
25,587
+14,112
+123% +$161K 0.05% 174
2023
Q2 		$153K Sell
11,475
-1,500
-12% -$18.2K 0.04% 180
2023
Q1 		$150K Sell
12,975
-3,058
-19% -$30.4K 0.04% 184
2022
Q4 		$131K Buy
+16,033
New +$138K 0.03% 186

Other funds holding PACB

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DWM
DKM Wealth Management Stockton, California $158M AUM 11.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Mirador Capital Partners's PACB Position: Q3 2026 in Review

Mirador Capital Partners reduced its Pacific Biosciences (PACB) stake by 0.22% in Q3 2026, selling an estimated $1.07K and leaving 341,725 shares worth $810K. The position accounts for 0.09% of the portfolio, ranked #123.

Mirador Capital Partners first reported a position in PACB in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.19M in Q1 2024. 7 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Mirador Capital Partners held 341,725 shares of Pacific Biosciences worth $810K as of Q3 2026.
  • Mirador Capital Partners sold 757 Pacific Biosciences shares in Q3 2026, an estimated $1.07K.
  • Pacific Biosciences made up 0.09% of Mirador Capital Partners's portfolio in Q3 2026, its #123 holding.
  • Mirador Capital Partners first reported a position in Pacific Biosciences in Q4 2022 and has held it in 16 quarters since.
  • Mirador Capital Partners's Pacific Biosciences position peaked at $1.19M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Mirador Capital Partners's 13F filing for Q3 2026, filed 9 Oct 2026.